Latest work by Prof. Uri Samuni (Queens College) & collaborators presents a new class of prostate-specific membrane antigen (PSMA)-targeting peptides for selective small interfering RNA (siRNA) delivery in prostate cancer (PCa) cells.
Read in the Molecular Therapy Family Of Journals: https://bit.ly/2P7UJGh
This entry is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license.
